Compare CTKB & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | EVH |
|---|---|---|
| Founded | 1990 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 541.1M | 520.1M |
| IPO Year | 2021 | 2015 |
| Metric | CTKB | EVH |
|---|---|---|
| Price | $5.83 | $4.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | ★ $6.17 | $5.75 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $193,015,000.00 | ★ $907,957,000.00 |
| Revenue This Year | $3.82 | $40.46 |
| Revenue Next Year | $6.49 | $25.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.67 | N/A |
| 52 Week Low | $3.31 | $2.10 |
| 52 Week High | $6.21 | $7.66 |
| Indicator | CTKB | EVH |
|---|---|---|
| Relative Strength Index (RSI) | 62.19 | 52.80 |
| Support Level | $4.17 | $4.31 |
| Resistance Level | $6.21 | $4.54 |
| Average True Range (ATR) | 0.26 | 0.31 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 91.77 | 50.00 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.